NFAT and Osterix cooperatively regulate bone formation

Nature Medicine

Volumn 11, Issue 8, 2005, Pages 880-885

  Koga, Takako ^a,b,f   Matsui, Yuichi ^c,d   Asagiri, Masataka ^a,b,f   Kodama, Tatsuhiko ^d   De Crombrugghe, Benoit ^e   Nakashima, Kazuhisa ^a,f   Takayanagi, Hiroshi ^a,b,f  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f Frontier Research on Molecular Destruction and Reconstruction of Tooth and Bone   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; COLLAGEN TYPE 1; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; OSTEOCALCIN; REGULATOR PROTEIN; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ARTICLE; BGLAP1 GENE; BONE MASS; BONE REGENERATION; CELL DIFFERENTIATION; COL1A1 GENE; CONTROLLED STUDY; DRUG EFFECT; GENE; GENE ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; MALE; MOUSE; NFATC1 GENE; NFATC2 GENE; NONHUMAN; ORGAN TRANSPLANTATION; OSSIFICATION; OSTEOCLAST; OSTEOPENIA; OSTEOPOROSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM;

ANIMALS; BONE DEVELOPMENT; CALCINEURIN; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; IMMUNOPRECIPITATION; IMMUNOSUPPRESSIVE AGENTS; LUCIFERASES; MICE; MICE, INBRED C57BL; NFATC TRANSCRIPTION FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TACROLIMUS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 23844515714     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1270     Document Type: Article

References (30)

1. Rodino, M.A. & Shane, E. Osteoporosis after organ transplantation. Am. J. Med. 104, 459-469 (1998).
2. Leidig-Bruckner, G. et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 357, 342-347 (2001).
3. Liu, J. et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815 (1991).
4. Hogan, P.G., Chen, L., Nardone, J. & Rao, A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205-2232 (2003).
5. Crabtree, G.R. & Olson, E.N. NFAT signaling: choreographing the social lives of cells. Cell 109 Suppl., S67-S79 (2002).
6. Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901 (2002).
7. Koga, T. et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428, 758-763 (2004).
8. Nakashima, K. et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29 (2002).
9. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L. & Karsenty, G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754 (1997).
10. Karsenty, G. & Wagner, E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389-406 (2002).
11. Cvetkovic, M. et al. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation 57, 1231-1237 (1994).
12. Fukunaga, J. et al. Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506. Bone 34, 425-431 (2004).
13. Wang, E.A. et al. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. USA 87, 2220-2224 (1990).
14. Tang, L. et al. FK506 enhanced osteoblastic differentiation in mesenchymal cells. Cell Biol. Int. 26, 75-84 (2002).
15. Ogawa, T. et al. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells. Biochem. Biophys. Res. Commun. 249, 226-230 (1998).
16. Murshed, M., Harmey, D., Millan, J.L., McKee, M.D. & Karsenty, G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 19, 1093-1104 (2005).
17. Ranger, A.M. et al. The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J. Exp. Med. 191, 9-22 (2000).
18. Tomita, M., Reinhold, M.I. & Molkentin, J.D. & Naski, M.C. Calcineurin and NFAT4 induce chondrogenesis. J. Biol. Chem. 277, 42214-42218 (2002).
19. Zhou, S., Glowacki, J. & Yates, K.E. Comparison of TGF-β/BMP pathway signaled by demineralized bone powder and BMP-2 in human dermal fibroblasts. J. Bone Miner. Res. 19, 1732-1741 (2004).
20. Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764 (1997).
21. Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771 (1997).
22. Massague, J. How cells read TGF-β signals. Nat. Rev. Mol. Cell Biol. 1, 169-178 (2000).
23. de la Pompa, J.L. et al. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392, 182-186 (1998).
24. Ranger, A.M. et al. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392, 186-190 (1998).
25. Blackham, A. & Griffiths, R.J. The effect of FK506 and cyclosporin A on antigen-induced arthritis. Clin. Exp. Immunol. 86, 224-228 (1991).
26. Yocum, D.E. et al. Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial. Arthritis Rheum. 48, 3328-3337 (2003).
27. Takayanagi, H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med. 83, 170-179 (2005).
28. Kim, S. et al. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev. 17, 1979-1991 (2003).
29. Hodge, M.R. et al. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4, 397-405 (1996).
30. Takayanagi, H. et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408, 600-605 (2000).